Rankings
▼
Calendar
VSTM Q1 2021 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$388M
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
-80.1% YoY
Gross Profit
$1M
100.0% margin
Operating Income
-$14M
-1402.4% margin
Net Income
-$15M
-1494.1% margin
EPS (Diluted)
$-1.08
QoQ Revenue Growth
+98.8%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$20M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$137M
Total Liabilities
$34M
Stockholders' Equity
$103M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$5M
-80.1%
Gross Profit
$1M
$4M
-75.9%
Operating Income
-$14M
-$26M
+46.5%
Net Income
-$15M
-$38M
+60.4%
Revenue Segments
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$67,000
68%
Product Revenue And Allowances Returns
$28,000
28%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$4,000
4%
← FY 2021
All Quarters
Q2 2021 →